FDA clears Vascular Solutions' lower-cost sealing device:
This article was originally published in Clinica
The US FDA has approved Vascular Solutions' PMA Supplement for its Diagnostic Duett sealing device - a less expensive version of its original Duett device tailored to treat diagnostic patients. The procoagulant in the new device is dosed for less-challenging diagnostic patients where substantial blood-thinning drugs are used less frequently, resulting in lower costs. The original Duett device is still effective for over 2.5 million diagnostic procedures in the US annually, says the Minneapolis, Minnesota firm, which this month plans to launch a flowable haemostat, D-Stat, that contains the same procoagulant components as that found in the Duett device.